Clinical Trials Directory

Trials / Unknown

UnknownNCT00810914

Patient Controlled Epidural Analgesia Versus Continuous Epidural Infusion: Obstetrical and Neonatal Outcomes

Patient Controlled Epidural Infusion Vs. Continuous Epidural Infusion: Obstetrical and Neonatal Outcomes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
270 (estimated)
Sponsor
MemorialCare · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigators intend to perform a large randomized trial using standardized obstetrical and anesthetic practice at a single institution to determine the effects of patient controlled epidural analgesia on obstetrical and neonatal outcomes.

Detailed description

Women in their first pregnancy in spontaneous labor desiring epidural anesthesia will be randomized to one of three groups. Each group will initially be given intrathecal bolus. Before and 30 minutes after the initial bolus, the patient's verbal pain score will be recorded. The continuous epidural infusion group (Group I) will be started immediately on a continuous pump infusion.They will also have the opportunity to give a PCA bolus Finally, the patient controlled epidural group (Group III) will be able to give a bolus every 20 minutes with no continuous infusion. Each group will also be allowed 2 boluses,by the anesthesia staff in the event that their pain is not controlled by the indicated study medication. An hourly evaluation of verbal pain score and maternal mobility will be recorded. After delivery, obstetrical outcomes, neonatal outcomes, anesthesia interventions, and patient satisfaction questionnaires will then be collected.

Conditions

Interventions

TypeNameDescription
DRUGbupivicaine epiduralbupivicaine continuous epidural infusion
DRUGbupivicaine epidural infusion patient epiduralbupivicaine
DRUGbupivicainepatient controlled anesthesia only

Timeline

Start date
2006-03-01
Primary completion
2010-06-01
Completion
2010-12-01
First posted
2008-12-18
Last updated
2009-09-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00810914. Inclusion in this directory is not an endorsement.